{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Orem",
      "address_1": "1272 S 1380 W",
      "reason_for_recall": "Lack of Sterility Assurance and Incorrect/Undeclared excipient: Product was found to contain undeclared colloidal silver",
      "address_2": "",
      "product_quantity": "10,297 bottles",
      "code_info": "All Lots",
      "center_classification_date": "20190114",
      "distribution_pattern": "Nationwide within the United States",
      "state": "UT",
      "product_description": "Lubrisine eye drops (polyethylene glycol 400 0.4% and Propylene glycol 0.3%), 30 ML bottle, Manufactured and Distributed by: Results RNA, LLC, 1272 S 1380 W., Orem, UT 84058, UPC 7 9238230723 4",
      "report_date": "20181226",
      "classification": "Class I",
      "openfda": {},
      "recalling_firm": "Results RNA, LLC",
      "recall_number": "D-0360-2019",
      "initial_firm_notification": "Telephone",
      "product_type": "Drugs",
      "event_id": "81742",
      "termination_date": "20210129",
      "more_code_info": "",
      "recall_initiation_date": "20181214",
      "postal_code": "84058-4911",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}